Healthcare

IBB must recapture and retest the $270 level to classify it as support.
FDA decision will impact Relypsa's buyout potential while Aritana won't stay this undervalued.
Health care has been a pricing business for GE, but William Blair says the industrial giant may soon be turning things around.
AbbVie and Gilead Sciences are worth accumulating in a long and deep bear market for biotech.
The Canadian drugmaker's standoff with creditors escalated Friday after it received a notice of default from bondholders.
Just as shares of the drugmaker were beginning to pick up steam, analysts with Wells Fargo Capital quickly put out the rally.

Novice Trade: Health Care ETF Real Money Pro($)

This is a trade expressing the view that flat-to-lower prices are ahead.
A potentially bullish pattern is setting up. 
Shares of the struggling Canadian drugmaker continue a two-day rally  off news its most notorious short seller has changed his course.
One day after announcing a long position on Valeant, Andrew Left of Citron Research makes it clear he's still not a fan of Mallinckrodt.

Columnist Conversations

Nice finish today for CVX. The stock has been steadily improving after holding key support near the $98.0...
TMO agreed to purchase FEI Company for S4.2 billion dollars this morning. The company ran a call earlier this ...
I noted back at the <a href="https://www.thestreet.com/story/13558749/1/berkshire-hathaway-s-rally-is-showi...
Hewlett-Packard is ramping today following last night's earnings report. The stock has been well bid sinc...

REAL MONEY'S BEST IDEAS

News Breaks

Powered by

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.